Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients
NCT04984941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-08-02
Summary
One hundred patients were enrolled, based on sensitization and doctor-diagnosed allergy to HDM. Questionnaires were administered to document demographic and clinical characteristics. Serum IgE reactivity toDermatophagoides pteronyssinus (Dp) extract, Der p 1, Der p 2 and Der p 10 was measured by ImmunoCAP.
Conditions
- Asthma
- Allergic Rhinitis
- Conjunctivitis
- Atopic Dermatitis
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Principal Investigators
-
Wang Huiying · 2nd affiliated Hospital,School of Medicine,Zhejiang University,China
Eligibility
- Min Age
- 3 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-01
- Primary Completion
- 2014-03-01
- Completion
- 2014-10-01
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.
NCT01795846 ·Status: UNKNOWN
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
NCT06920771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Dust Mite Inhalation in Humans
NCT00448851 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma
NCT01930461 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients
NCT03094845 ·Status: COMPLETED ·Phase: PHASE2
-
Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
NCT01485523 ·Status: COMPLETED
-
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
NCT02443805 ·Status: COMPLETED ·Phase: PHASE3
-
House Dust Mite Allergy Trial In Children
NCT04145219 ·Status: COMPLETED ·Phase: PHASE3
-
ToleroMune House Dust Mite (HDM) Tolerability Study
NCT01949441 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885 ·Status: RECRUITING ·Phase: PHASE3
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents
NCT01919554 ·Status: COMPLETED ·Phase: PHASE1
-
House Dust Mite Induced Inflammasome Activation on Corticosteroid Resistance
NCT03307278 ·Status: WITHDRAWN ·Phase: NA
-
Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis
NCT06151938 ·Status: ENROLLING_BY_INVITATION
-
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
NCT05570383 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Mite Asthma Pediatric Immunotherapy Trial
NCT03654976 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
NCT03023397 ·Status: TERMINATED ·Phase: PHASE1
-
An Optional Investigation of Biomarkers of Efficacy
NCT01949415 ·Status: COMPLETED
-
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
NCT01608243 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis
NCT02301884 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
NCT02340130 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis
NCT01008332 ·Status: COMPLETED ·Phase: PHASE2
-
Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients
NCT01179282 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
NCT04184895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1